Additional outcomes investigated included how cognitive scores were influenced by APOE4 genotype status, as our earlier acute dosing study suggested that AD patients who lacked an APOE4 allele may respond better to ketosis [31]. This evidence concerns the gene APOE and Alzheimer disease.